Serveur d'exploration SRAS

Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.

Broad-Spectrum In Vitro Activity and In Vivo Efficacy of the Antiviral Protein Griffithsin against Emerging Viruses of the Family Coronaviridae

Identifieur interne : 002947 ( Main/Exploration ); précédent : 002946; suivant : 002948

Broad-Spectrum In Vitro Activity and In Vivo Efficacy of the Antiviral Protein Griffithsin against Emerging Viruses of the Family Coronaviridae

Auteurs : Barry R. O'Keefe [États-Unis] ; Barbara Giomarelli [États-Unis] ; Dale L. Barnard [États-Unis] ; Shilpa R. Shenoy [États-Unis] ; Paul K. S. Chan [Hong Kong] ; James B. Mcmahon [États-Unis] ; Kenneth E. Palmer [États-Unis] ; Brian W. Barnett [États-Unis] ; David K. Meyerholz [États-Unis] ; Christine L. Wohlford-Lenane [États-Unis] ; Paul B. Jr Mccray [États-Unis]

Source :

RBID : Pascal:10-0140088

Descripteurs français

English descriptors

Abstract

Viruses of the family Coronaviridae have recently emerged through zoonotic transmission to become serious human pathogens. The pathogenic agent responsible for severe acute respiratory syndrome (SARS), the SARS coronavirus (SARS-CoV), is a member of this large family of positive-strand RNA viruses that cause a spectrum of disease in humans, other mammals, and birds. Since the publicized outbreaks of SARS in China and Canada in 2002-2003, significant efforts successfully identified the causative agent, host cell receptor(s), and many of the pathogenic mechanisms underlying SARS. With this greater understanding of SARS-CoV biology, many researchers have sought to identify agents for the treatment of SARS. Here we report the utility of the potent antiviral protein griffithsin (GRFT) in the prevention of SARS-CoV infection both in vitro and in vivo. We also show that GRFT specifically binds to the SARS-CoV spike glycoprotein and inhibits viral entry. In addition, we report the activity of GRFT against a variety of additional coronaviruses that infect humans, other mammals, and birds. Finally, we show that GRFT treatment has a positive effect on morbidity and mortality in a lethal infection model using a mouse-adapted SARS-CoV and also specifically inhibits deleterious aspects of the host immunological response to SARS infection in mammals.


Affiliations:


Links toward previous steps (curation, corpus...)


Le document en format XML

<record>
<TEI>
<teiHeader>
<fileDesc>
<titleStmt>
<title xml:lang="en" level="a">Broad-Spectrum In Vitro Activity and In Vivo Efficacy of the Antiviral Protein Griffithsin against Emerging Viruses of the Family Coronaviridae</title>
<author>
<name sortKey="O Keefe, Barry R" sort="O Keefe, Barry R" uniqKey="O Keefe B" first="Barry R." last="O'Keefe">Barry R. O'Keefe</name>
<affiliation wicri:level="2">
<inist:fA14 i1="01">
<s1>Molecular Targets Development Program, Center for Cancer Research, NCI-Frederick</s1>
<s2>Frederick Maryland 21702</s2>
<s3>USA</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>6 aut.</sZ>
</inist:fA14>
<country>États-Unis</country>
<placeName>
<region type="state">Caroline du Nord</region>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Giomarelli, Barbara" sort="Giomarelli, Barbara" uniqKey="Giomarelli B" first="Barbara" last="Giomarelli">Barbara Giomarelli</name>
<affiliation wicri:level="2">
<inist:fA14 i1="01">
<s1>Molecular Targets Development Program, Center for Cancer Research, NCI-Frederick</s1>
<s2>Frederick Maryland 21702</s2>
<s3>USA</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>6 aut.</sZ>
</inist:fA14>
<country>États-Unis</country>
<placeName>
<region type="state">Caroline du Nord</region>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Barnard, Dale L" sort="Barnard, Dale L" uniqKey="Barnard D" first="Dale L." last="Barnard">Dale L. Barnard</name>
<affiliation wicri:level="2">
<inist:fA14 i1="02">
<s1>Utah State University</s1>
<s2>Logan, Utah</s2>
<s3>USA</s3>
<sZ>3 aut.</sZ>
</inist:fA14>
<country>États-Unis</country>
<placeName>
<region type="state">Utah</region>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Shenoy, Shilpa R" sort="Shenoy, Shilpa R" uniqKey="Shenoy S" first="Shilpa R." last="Shenoy">Shilpa R. Shenoy</name>
<affiliation wicri:level="1">
<inist:fA14 i1="03">
<s1>SAIC-Frederick</s1>
<s2>Frederick, Maryland 21702</s2>
<s3>USA</s3>
<sZ>4 aut.</sZ>
</inist:fA14>
<country>États-Unis</country>
<wicri:noRegion>SAIC-Frederick</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Chan, Paul K S" sort="Chan, Paul K S" uniqKey="Chan P" first="Paul K. S." last="Chan">Paul K. S. Chan</name>
<affiliation wicri:level="4">
<inist:fA14 i1="04">
<s1>Chinese University of Hong Kong</s1>
<s3>HKG</s3>
<sZ>5 aut.</sZ>
</inist:fA14>
<country>Hong Kong</country>
<placeName>
<settlement type="city">Sha Tin</settlement>
</placeName>
<orgName type="university">Université chinoise de Hong Kong</orgName>
</affiliation>
</author>
<author>
<name sortKey="Mcmahon, James B" sort="Mcmahon, James B" uniqKey="Mcmahon J" first="James B." last="Mcmahon">James B. Mcmahon</name>
<affiliation wicri:level="2">
<inist:fA14 i1="01">
<s1>Molecular Targets Development Program, Center for Cancer Research, NCI-Frederick</s1>
<s2>Frederick Maryland 21702</s2>
<s3>USA</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>6 aut.</sZ>
</inist:fA14>
<country>États-Unis</country>
<placeName>
<region type="state">Caroline du Nord</region>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Palmer, Kenneth E" sort="Palmer, Kenneth E" uniqKey="Palmer K" first="Kenneth E." last="Palmer">Kenneth E. Palmer</name>
<affiliation wicri:level="1">
<inist:fA14 i1="05">
<s1>James Graham Brown Cancer Center and Department of Pharmacology and Toxicology, University of Louisville</s1>
<s2>Louisville, Kentucky 40202</s2>
<s3>USA</s3>
<sZ>7 aut.</sZ>
<sZ>8 aut.</sZ>
</inist:fA14>
<country>États-Unis</country>
<wicri:noRegion>Louisville, Kentucky 40202</wicri:noRegion>
</affiliation>
<affiliation wicri:level="1">
<inist:fA14 i1="06">
<s1>Owensboro Cancer Research Program</s1>
<s2>Owensboro, Kentucky 42303</s2>
<s3>USA</s3>
<sZ>7 aut.</sZ>
</inist:fA14>
<country>États-Unis</country>
<wicri:noRegion>Owensboro Cancer Research Program</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Barnett, Brian W" sort="Barnett, Brian W" uniqKey="Barnett B" first="Brian W." last="Barnett">Brian W. Barnett</name>
<affiliation wicri:level="1">
<inist:fA14 i1="05">
<s1>James Graham Brown Cancer Center and Department of Pharmacology and Toxicology, University of Louisville</s1>
<s2>Louisville, Kentucky 40202</s2>
<s3>USA</s3>
<sZ>7 aut.</sZ>
<sZ>8 aut.</sZ>
</inist:fA14>
<country>États-Unis</country>
<wicri:noRegion>Louisville, Kentucky 40202</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Meyerholz, David K" sort="Meyerholz, David K" uniqKey="Meyerholz D" first="David K." last="Meyerholz">David K. Meyerholz</name>
<affiliation wicri:level="4">
<inist:fA14 i1="07">
<s1>Department of Pathology, Carver College of Medicine, University of Iowa</s1>
<s2>Iowa City, Iowa 52242</s2>
<s3>USA</s3>
<sZ>9 aut.</sZ>
<sZ>10 aut.</sZ>
</inist:fA14>
<country>États-Unis</country>
<placeName>
<settlement type="city">Iowa City</settlement>
<region type="state">Iowa</region>
</placeName>
<orgName type="university">Université de l'Iowa</orgName>
</affiliation>
</author>
<author>
<name sortKey="Wohlford Lenane, Christine L" sort="Wohlford Lenane, Christine L" uniqKey="Wohlford Lenane C" first="Christine L." last="Wohlford-Lenane">Christine L. Wohlford-Lenane</name>
<affiliation wicri:level="4">
<inist:fA14 i1="07">
<s1>Department of Pathology, Carver College of Medicine, University of Iowa</s1>
<s2>Iowa City, Iowa 52242</s2>
<s3>USA</s3>
<sZ>9 aut.</sZ>
<sZ>10 aut.</sZ>
</inist:fA14>
<country>États-Unis</country>
<placeName>
<settlement type="city">Iowa City</settlement>
<region type="state">Iowa</region>
</placeName>
<orgName type="university">Université de l'Iowa</orgName>
</affiliation>
</author>
<author>
<name sortKey="Mccray, Paul B Jr" sort="Mccray, Paul B Jr" uniqKey="Mccray P" first="Paul B. Jr" last="Mccray">Paul B. Jr Mccray</name>
<affiliation wicri:level="4">
<inist:fA14 i1="08">
<s1>Department of Pediatrics, Carver College of Medicine, University of Iowa</s1>
<s2>Iowa City, Iowa 52242</s2>
<s3>USA</s3>
<sZ>11 aut.</sZ>
</inist:fA14>
<country>États-Unis</country>
<placeName>
<settlement type="city">Iowa City</settlement>
<region type="state">Iowa</region>
</placeName>
<orgName type="university">Université de l'Iowa</orgName>
</affiliation>
<affiliation wicri:level="4">
<inist:fA14 i1="09">
<s1>Department of Microbiology, Carver College of Medicine, University of Iowa</s1>
<s2>Iowa City, Iowa 52242</s2>
<s3>USA</s3>
<sZ>11 aut.</sZ>
</inist:fA14>
<country>États-Unis</country>
<placeName>
<settlement type="city">Iowa City</settlement>
<region type="state">Iowa</region>
</placeName>
<orgName type="university">Université de l'Iowa</orgName>
</affiliation>
</author>
</titleStmt>
<publicationStmt>
<idno type="wicri:source">INIST</idno>
<idno type="inist">10-0140088</idno>
<date when="2010">2010</date>
<idno type="stanalyst">PASCAL 10-0140088 INIST</idno>
<idno type="RBID">Pascal:10-0140088</idno>
<idno type="wicri:Area/PascalFrancis/Corpus">000169</idno>
<idno type="wicri:Area/PascalFrancis/Curation">000819</idno>
<idno type="wicri:Area/PascalFrancis/Checkpoint">000158</idno>
<idno type="wicri:explorRef" wicri:stream="PascalFrancis" wicri:step="Checkpoint">000158</idno>
<idno type="wicri:doubleKey">0022-538X:2010:O Keefe B:broad:spectrum:in</idno>
<idno type="wicri:Area/Main/Merge">002990</idno>
<idno type="wicri:Area/Main/Curation">002947</idno>
<idno type="wicri:Area/Main/Exploration">002947</idno>
</publicationStmt>
<sourceDesc>
<biblStruct>
<analytic>
<title xml:lang="en" level="a">Broad-Spectrum In Vitro Activity and In Vivo Efficacy of the Antiviral Protein Griffithsin against Emerging Viruses of the Family Coronaviridae</title>
<author>
<name sortKey="O Keefe, Barry R" sort="O Keefe, Barry R" uniqKey="O Keefe B" first="Barry R." last="O'Keefe">Barry R. O'Keefe</name>
<affiliation wicri:level="2">
<inist:fA14 i1="01">
<s1>Molecular Targets Development Program, Center for Cancer Research, NCI-Frederick</s1>
<s2>Frederick Maryland 21702</s2>
<s3>USA</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>6 aut.</sZ>
</inist:fA14>
<country>États-Unis</country>
<placeName>
<region type="state">Caroline du Nord</region>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Giomarelli, Barbara" sort="Giomarelli, Barbara" uniqKey="Giomarelli B" first="Barbara" last="Giomarelli">Barbara Giomarelli</name>
<affiliation wicri:level="2">
<inist:fA14 i1="01">
<s1>Molecular Targets Development Program, Center for Cancer Research, NCI-Frederick</s1>
<s2>Frederick Maryland 21702</s2>
<s3>USA</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>6 aut.</sZ>
</inist:fA14>
<country>États-Unis</country>
<placeName>
<region type="state">Caroline du Nord</region>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Barnard, Dale L" sort="Barnard, Dale L" uniqKey="Barnard D" first="Dale L." last="Barnard">Dale L. Barnard</name>
<affiliation wicri:level="2">
<inist:fA14 i1="02">
<s1>Utah State University</s1>
<s2>Logan, Utah</s2>
<s3>USA</s3>
<sZ>3 aut.</sZ>
</inist:fA14>
<country>États-Unis</country>
<placeName>
<region type="state">Utah</region>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Shenoy, Shilpa R" sort="Shenoy, Shilpa R" uniqKey="Shenoy S" first="Shilpa R." last="Shenoy">Shilpa R. Shenoy</name>
<affiliation wicri:level="1">
<inist:fA14 i1="03">
<s1>SAIC-Frederick</s1>
<s2>Frederick, Maryland 21702</s2>
<s3>USA</s3>
<sZ>4 aut.</sZ>
</inist:fA14>
<country>États-Unis</country>
<wicri:noRegion>SAIC-Frederick</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Chan, Paul K S" sort="Chan, Paul K S" uniqKey="Chan P" first="Paul K. S." last="Chan">Paul K. S. Chan</name>
<affiliation wicri:level="4">
<inist:fA14 i1="04">
<s1>Chinese University of Hong Kong</s1>
<s3>HKG</s3>
<sZ>5 aut.</sZ>
</inist:fA14>
<country>Hong Kong</country>
<placeName>
<settlement type="city">Sha Tin</settlement>
</placeName>
<orgName type="university">Université chinoise de Hong Kong</orgName>
</affiliation>
</author>
<author>
<name sortKey="Mcmahon, James B" sort="Mcmahon, James B" uniqKey="Mcmahon J" first="James B." last="Mcmahon">James B. Mcmahon</name>
<affiliation wicri:level="2">
<inist:fA14 i1="01">
<s1>Molecular Targets Development Program, Center for Cancer Research, NCI-Frederick</s1>
<s2>Frederick Maryland 21702</s2>
<s3>USA</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>6 aut.</sZ>
</inist:fA14>
<country>États-Unis</country>
<placeName>
<region type="state">Caroline du Nord</region>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Palmer, Kenneth E" sort="Palmer, Kenneth E" uniqKey="Palmer K" first="Kenneth E." last="Palmer">Kenneth E. Palmer</name>
<affiliation wicri:level="1">
<inist:fA14 i1="05">
<s1>James Graham Brown Cancer Center and Department of Pharmacology and Toxicology, University of Louisville</s1>
<s2>Louisville, Kentucky 40202</s2>
<s3>USA</s3>
<sZ>7 aut.</sZ>
<sZ>8 aut.</sZ>
</inist:fA14>
<country>États-Unis</country>
<wicri:noRegion>Louisville, Kentucky 40202</wicri:noRegion>
</affiliation>
<affiliation wicri:level="1">
<inist:fA14 i1="06">
<s1>Owensboro Cancer Research Program</s1>
<s2>Owensboro, Kentucky 42303</s2>
<s3>USA</s3>
<sZ>7 aut.</sZ>
</inist:fA14>
<country>États-Unis</country>
<wicri:noRegion>Owensboro Cancer Research Program</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Barnett, Brian W" sort="Barnett, Brian W" uniqKey="Barnett B" first="Brian W." last="Barnett">Brian W. Barnett</name>
<affiliation wicri:level="1">
<inist:fA14 i1="05">
<s1>James Graham Brown Cancer Center and Department of Pharmacology and Toxicology, University of Louisville</s1>
<s2>Louisville, Kentucky 40202</s2>
<s3>USA</s3>
<sZ>7 aut.</sZ>
<sZ>8 aut.</sZ>
</inist:fA14>
<country>États-Unis</country>
<wicri:noRegion>Louisville, Kentucky 40202</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Meyerholz, David K" sort="Meyerholz, David K" uniqKey="Meyerholz D" first="David K." last="Meyerholz">David K. Meyerholz</name>
<affiliation wicri:level="4">
<inist:fA14 i1="07">
<s1>Department of Pathology, Carver College of Medicine, University of Iowa</s1>
<s2>Iowa City, Iowa 52242</s2>
<s3>USA</s3>
<sZ>9 aut.</sZ>
<sZ>10 aut.</sZ>
</inist:fA14>
<country>États-Unis</country>
<placeName>
<settlement type="city">Iowa City</settlement>
<region type="state">Iowa</region>
</placeName>
<orgName type="university">Université de l'Iowa</orgName>
</affiliation>
</author>
<author>
<name sortKey="Wohlford Lenane, Christine L" sort="Wohlford Lenane, Christine L" uniqKey="Wohlford Lenane C" first="Christine L." last="Wohlford-Lenane">Christine L. Wohlford-Lenane</name>
<affiliation wicri:level="4">
<inist:fA14 i1="07">
<s1>Department of Pathology, Carver College of Medicine, University of Iowa</s1>
<s2>Iowa City, Iowa 52242</s2>
<s3>USA</s3>
<sZ>9 aut.</sZ>
<sZ>10 aut.</sZ>
</inist:fA14>
<country>États-Unis</country>
<placeName>
<settlement type="city">Iowa City</settlement>
<region type="state">Iowa</region>
</placeName>
<orgName type="university">Université de l'Iowa</orgName>
</affiliation>
</author>
<author>
<name sortKey="Mccray, Paul B Jr" sort="Mccray, Paul B Jr" uniqKey="Mccray P" first="Paul B. Jr" last="Mccray">Paul B. Jr Mccray</name>
<affiliation wicri:level="4">
<inist:fA14 i1="08">
<s1>Department of Pediatrics, Carver College of Medicine, University of Iowa</s1>
<s2>Iowa City, Iowa 52242</s2>
<s3>USA</s3>
<sZ>11 aut.</sZ>
</inist:fA14>
<country>États-Unis</country>
<placeName>
<settlement type="city">Iowa City</settlement>
<region type="state">Iowa</region>
</placeName>
<orgName type="university">Université de l'Iowa</orgName>
</affiliation>
<affiliation wicri:level="4">
<inist:fA14 i1="09">
<s1>Department of Microbiology, Carver College of Medicine, University of Iowa</s1>
<s2>Iowa City, Iowa 52242</s2>
<s3>USA</s3>
<sZ>11 aut.</sZ>
</inist:fA14>
<country>États-Unis</country>
<placeName>
<settlement type="city">Iowa City</settlement>
<region type="state">Iowa</region>
</placeName>
<orgName type="university">Université de l'Iowa</orgName>
</affiliation>
</author>
</analytic>
<series>
<title level="j" type="main">Journal of virology</title>
<title level="j" type="abbreviated">J. virol.</title>
<idno type="ISSN">0022-538X</idno>
<imprint>
<date when="2010">2010</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
<seriesStmt>
<title level="j" type="main">Journal of virology</title>
<title level="j" type="abbreviated">J. virol.</title>
<idno type="ISSN">0022-538X</idno>
</seriesStmt>
</fileDesc>
<profileDesc>
<textClass>
<keywords scheme="KwdEn" xml:lang="en">
<term>Antiviral</term>
<term>Biological activity</term>
<term>Efficiency</term>
<term>Griffithsin</term>
<term>In vitro</term>
<term>Mechanism of action</term>
<term>Protein</term>
<term>Severe acute respiratory syndrome virus</term>
</keywords>
<keywords scheme="Pascal" xml:lang="fr">
<term>Virus syndrome respiratoire aigu sévère</term>
<term>Activité biologique</term>
<term>In vitro</term>
<term>Efficacité</term>
<term>Antiviral</term>
<term>Protéine</term>
<term>Mécanisme action</term>
<term>Griffithsine</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front>
<div type="abstract" xml:lang="en">Viruses of the family Coronaviridae have recently emerged through zoonotic transmission to become serious human pathogens. The pathogenic agent responsible for severe acute respiratory syndrome (SARS), the SARS coronavirus (SARS-CoV), is a member of this large family of positive-strand RNA viruses that cause a spectrum of disease in humans, other mammals, and birds. Since the publicized outbreaks of SARS in China and Canada in 2002-2003, significant efforts successfully identified the causative agent, host cell receptor(s), and many of the pathogenic mechanisms underlying SARS. With this greater understanding of SARS-CoV biology, many researchers have sought to identify agents for the treatment of SARS. Here we report the utility of the potent antiviral protein griffithsin (GRFT) in the prevention of SARS-CoV infection both in vitro and in vivo. We also show that GRFT specifically binds to the SARS-CoV spike glycoprotein and inhibits viral entry. In addition, we report the activity of GRFT against a variety of additional coronaviruses that infect humans, other mammals, and birds. Finally, we show that GRFT treatment has a positive effect on morbidity and mortality in a lethal infection model using a mouse-adapted SARS-CoV and also specifically inhibits deleterious aspects of the host immunological response to SARS infection in mammals.</div>
</front>
</TEI>
<affiliations>
<list>
<country>
<li>Hong Kong</li>
<li>États-Unis</li>
</country>
<region>
<li>Caroline du Nord</li>
<li>Iowa</li>
<li>Utah</li>
</region>
<settlement>
<li>Iowa City</li>
<li>Sha Tin</li>
</settlement>
<orgName>
<li>Université chinoise de Hong Kong</li>
<li>Université de l'Iowa</li>
</orgName>
</list>
<tree>
<country name="États-Unis">
<region name="Caroline du Nord">
<name sortKey="O Keefe, Barry R" sort="O Keefe, Barry R" uniqKey="O Keefe B" first="Barry R." last="O'Keefe">Barry R. O'Keefe</name>
</region>
<name sortKey="Barnard, Dale L" sort="Barnard, Dale L" uniqKey="Barnard D" first="Dale L." last="Barnard">Dale L. Barnard</name>
<name sortKey="Barnett, Brian W" sort="Barnett, Brian W" uniqKey="Barnett B" first="Brian W." last="Barnett">Brian W. Barnett</name>
<name sortKey="Giomarelli, Barbara" sort="Giomarelli, Barbara" uniqKey="Giomarelli B" first="Barbara" last="Giomarelli">Barbara Giomarelli</name>
<name sortKey="Mccray, Paul B Jr" sort="Mccray, Paul B Jr" uniqKey="Mccray P" first="Paul B. Jr" last="Mccray">Paul B. Jr Mccray</name>
<name sortKey="Mccray, Paul B Jr" sort="Mccray, Paul B Jr" uniqKey="Mccray P" first="Paul B. Jr" last="Mccray">Paul B. Jr Mccray</name>
<name sortKey="Mcmahon, James B" sort="Mcmahon, James B" uniqKey="Mcmahon J" first="James B." last="Mcmahon">James B. Mcmahon</name>
<name sortKey="Meyerholz, David K" sort="Meyerholz, David K" uniqKey="Meyerholz D" first="David K." last="Meyerholz">David K. Meyerholz</name>
<name sortKey="Palmer, Kenneth E" sort="Palmer, Kenneth E" uniqKey="Palmer K" first="Kenneth E." last="Palmer">Kenneth E. Palmer</name>
<name sortKey="Palmer, Kenneth E" sort="Palmer, Kenneth E" uniqKey="Palmer K" first="Kenneth E." last="Palmer">Kenneth E. Palmer</name>
<name sortKey="Shenoy, Shilpa R" sort="Shenoy, Shilpa R" uniqKey="Shenoy S" first="Shilpa R." last="Shenoy">Shilpa R. Shenoy</name>
<name sortKey="Wohlford Lenane, Christine L" sort="Wohlford Lenane, Christine L" uniqKey="Wohlford Lenane C" first="Christine L." last="Wohlford-Lenane">Christine L. Wohlford-Lenane</name>
</country>
<country name="Hong Kong">
<noRegion>
<name sortKey="Chan, Paul K S" sort="Chan, Paul K S" uniqKey="Chan P" first="Paul K. S." last="Chan">Paul K. S. Chan</name>
</noRegion>
</country>
</tree>
</affiliations>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/SrasV1/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 002947 | SxmlIndent | more

Ou

HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 002947 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    SrasV1
   |flux=    Main
   |étape=   Exploration
   |type=    RBID
   |clé=     Pascal:10-0140088
   |texte=   Broad-Spectrum In Vitro Activity and In Vivo Efficacy of the Antiviral Protein Griffithsin against Emerging Viruses of the Family Coronaviridae
}}

Wicri

This area was generated with Dilib version V0.6.33.
Data generation: Tue Apr 28 14:49:16 2020. Site generation: Sat Mar 27 22:06:49 2021